Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AK(BA)), a biopharmaceutical company with the purpose to better the ...
Home » Akebia Therapeutics
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AK(BA)), a biopharmaceutical company with the purpose to better the ...
Akebia Therapeutics, Inc. (NASDAQ:AK(BA)) has earned an average recommendation of "Hold" from the eight ratings firms that are currently covering ...